COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 1891: Articles 18901-18910  | Next

PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern
Vogels, C. B., Breban, M., Alpert, T., Petrone, M. E., Watkins, A. E., Hodcroft, E., Mason, C. E., Khullar, G., Dudley, J. T., Mackay, M. J., Wang, J., Liu, C., Hui, P., Murphy, S., Neal, C., Laszlo, E., Landry, M. L., Muyombwe, A., Downing, R., Razeq, J., Neher, R. A., Fauver, J. R., Grubaugh, N. D.
10.1101/2021.01.28.21250486 — Posted: 2021-02-01
Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach
Kim, D., Pekgun, P., Yildirim, I., Keskinocak, P.
10.1101/2021.01.28.21250713 — Posted: 2021-02-01
Effect of RBD (Y453F) mutation in spike glycoprotein of SARS-CoV-2 on neutralizing IgG affinity.
Hayashi, T., Yaegashi, N., Konishi, I.
10.1101/2021.01.28.21250577 — Posted: 2021-02-01
Age significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays
Irwin, N., Murray, L., Ozynski, B., Richards, G. A., Paget, G., Venturas, J., Kalla, I., Diana, N., Mahomed, A., Zamparini, J.
10.1101/2021.01.28.21250675 — Posted: 2021-02-01
Targeting TGF-b pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19
Trieu, V., Saund, S., Rahate, P., Barge, V., Nalk, S., Windlass, H., Uckun, F.
10.1101/2021.01.24.21250418 — Posted: 2021-02-01 Discussion: Onsite
Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation
Fujimoto, A. B., Yildirim, I., Keskinocak, P.
10.1101/2021.01.28.21250721 — Posted: 2021-02-01
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers
Heaney, C. D., Pisanic, N., Randad, P. R., Kruczynski, K., Howard, T., Zhu, X., Littlefield, K., Patel, E., Shrestha, R., Laeyendecker, O., Shoham, S., Sullivan, D. J., Gebo, K., Hanley, D., Redd, A., Quinn, T., Casadevall, A., Zenilman, J. M., Pekosz, A., Bloch, E. M., Tobian, A. A.
10.1101/2021.01.28.21250717 — Posted: 2021-02-01
Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact
Braun, K. M., Moreno, G. K., Buys, A., Bobholz, M., Accola, M. A., Anderson, L., Rehrauer, W. M., Baker, D. A., Safdar, N., Lepak, A. J., O'Connor, D., Friedrich, T.
10.1101/2021.01.28.21250421 — Posted: 2021-02-01
Modeling the potential impact of indirect transmission on COVID-19 epidemic
David, J. F., Iyaniwura, S. A., Yuan, P., Tan, Y., Kong, J. D., Zhu, H.
10.1101/2021.01.28.20181040 — Posted: 2021-02-01
Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
Flisiak, R., Jaroszewicz, J., Rogalska, M., Lapinski, T., Berkan-Kawinska, A., Bolewska, B., Tudrujek-Zdunek, M., Kozielewicz, D., Rorat, M., Leszczynski, P., Klos, K., Kowalska, J., Pabjan, P., Piekarska, A., Mozer-Lisewska, I., Tomasiewicz, K., Pawlowska, M., Simon, K., Polanska, J., Zarebska-Michaluk, D.
10.1101/2021.01.28.21249932 — Posted: 2021-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).